Las Vegas Cannabis Testing News and More
This past week the FDA issued a series of warning letters to a handful of companies manufacturing and marketing cannabidiol (CBD) products. While these letters represent the second wave of similar warning letters issued in 2015, the FDA continues to side-step CBD itself and instead focus on the health-based therapeutic claims these companies have made. […]
Read MoreDr. Cindy Orser, the Chief Science Officer of DigiPath Labs, a subsidiary of DigiPath, Inc. (DIGP) will be a featured speaker at the Emerald Conference in Las Vegas on Thursday, January 21. Dr. Orser’s talk, entitled “Ensuring Patient Safety & Establishing Standardization in Cannabis Testing,” is scheduled for 1:30 p.m. Dr. Orser will cover the […]
Read More
With New Year’s Eve just hours away, the likelihood of law enforcement roadside checks for driving impairment will be spiking. And the question arises as to what are the per se laws when it comes to cannabis and in particular, THC and its metabolites. Unfortunately, legal limits for THC in blood or plasma have largely […]
Read More
Through the detailed cannabis genetic research of academicians, we are learning that the genetic identity of a marijuana strain cannot be reliably inferred by its strain name or by its reported ancestry; ie. indica versus sativa. In a recent article by Sawler et al. (2015), cannabis samples were found to be more genetically similar to […]
Read More
